Adefovir

Drug Profile

Adefovir

Alternative Names: GS 0393; GS 393; Phosphonylmethoxyethyl-a; PMEA

Latest Information Update: 21 Aug 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Academy of Sciences of the Czech Republic; Nonindustrial source; Rega Institute for Medical Research
  • Developer Academy of Sciences of the Czech Republic; Gilead Sciences; Nonindustrial source
  • Class Adenine nucleotides; Antiretrovirals; Phosphonic acids; Purine nucleotides; Small molecules
  • Mechanism of Action Cell differentiation stimulants; DNA-directed DNA polymerase inhibitors; Immunomodulators; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Graft-versus-host disease; Hepatitis B; HIV infections; Rheumatic disorders

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 08 May 2000 Discontinued-II for HIV infections treatment in USA (IV)
  • 08 May 2000 Discontinued-Preclinical for Hepatitis B in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top